mono-specific antisera against vibrio cholera ogawa nih-43 and vibrio cholera inaba 35-a3 were prepared from rabbit hyperimmune sera by absorbing against a heterologous strain. using ammonium sulphate precipitation procedure, gamma globulins were purified and concentrated. to visualize antigen-antibody reaction, gamma globulins were conjugated to staphylococcus aureus cowan-l (nctc: 8325) in th...

Mono-specific antisera against Vibrio cholera Ogawa NIH-43 and Vibrio cholera Inaba 35-A3 were prepared from rabbit hyperimmune sera by absorbing against a heterologous strain. Using ammonium sulphate precipitation procedure, gamma globulins were purified and concentrated. To visualize antigen-antibody reaction, gamma globulins were conjugated to Staphylococcus aureus cowan-l (NCTC: 8325) ...

We evaluated immune responses following bivalent oral cholera vaccination (Shanchol [Shantha Biotechnics]; BivWC) in a cohort of 25 human immunodeficiency virus (HIV)-infected adults in Haiti. Compared with adults without HIV infection, vaccination in HIV-infected individuals resulted in lower vibriocidal responses against Vibrio cholerae O1, and there was a positive relationship between the CD...

quick identification of vibrio cholerae in epidemics is   important, on the other hand; conventional methods are time-consuming and   costly. the aim of this study was to develop a rapid, inexpensive and high   sensitivity method for quick identification of vibrio cholerae . for   this purpose we designed a pcr detection based on magnetic nanoparticles for   identification of bacterial dna by p...

background several hundred thousand people are infected with vibrio cholera every year worldwide, with a case fatality rate over 2%. periodic cholera outbreaks are of important health issues in iran, especially in sistan and baluchistan province. objectives in this study, we evaluated cholera out breaks and related factors, during 2010-2013, to improve controlling the disease in this province. ...

BACKGROUND Efficacy and safety of a two-dose regimen of bivalent killed whole-cell oral cholera vaccine (Shantha Biotechnics, Hyderabad, India) to 3 years is established, but long-term efficacy is not. We aimed to assess protective efficacy up to 5 years in a slum area of Kolkata, India. METHODS In our double-blind, cluster-randomised, placebo-controlled trial, we assessed incidence of choler...

Introduction. Evaluation of antibiotic sensitivity biofilms formed by Vibrio cholerae can help in the search for effective drugs to combat cholera.
 The aim work is evaluate effectiveness antibacterial against V. cells being a part polymicrobial biofilm on various substrates.
 Materials and methods. Mono- were simulated vitro chitin plastic flasks containing tap autoclaved water conta...

Introduction.?Koch in 1883 isolated the cholera vibrio from cholera patients in Calcutta. Tinkler and Prior (1884) and Deneke (1885) described vibrios resembling Koch's vibrio that had been isolated from non-choleraic material. In the twelve years following the discovery of the cholera vibrio, Metchnikof, Sanarelli, Gunter, Foker oftid other workers isolated vibrios indistinguishable morphologi...

BACKGROUND Studies of the immunogenicity of the killed bivalent whole cell oral cholera vaccine, Shanchol, have been performed in historically cholera-endemic areas of Asia. There is a need to assess the immunogenicity of the vaccine in Haiti and other populations without historical exposure to Vibrio cholerae. METHODOLOGY/PRINCIPAL FINDINGS We measured immune responses after administration o...